Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (FY)Jun 30, 2025 | (Q4)Jun 30, 2025 | (Q2)Dec 31, 2024 | (Q1)Sep 30, 2024 | (FY)Jun 30, 2024 | (Q4)Jun 30, 2024 | (Q3)Mar 31, 2024 | (Q2)Dec 31, 2023 | (Q1)Sep 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -81.86%10.12M | -7.77%87.7M | 22.72%12.08M | -55.99%5.35M | -60.29%6.54M | 146.30%95.08M | 145.88%9.84M | 555.36%55.77M | 52.15%12.15M | -9.03%16.47M |
| Cost of revenue | -84.81%6.79M | 7.76%71.46M | 22.15%7.63M | -30.42%3.52M | -69.82%3.19M | 197.75%66.31M | 302.84%6.24M | 996.12%44.69M | 21.73%5.06M | -15.34%10.57M |
| Gross profit | -69.94%3.33M | -43.56%16.24M | 23.72%4.45M | -74.22%1.83M | -43.20%3.35M | 76.14%28.77M | 46.66%3.6M | 149.91%11.08M | 85.15%7.1M | 5.02%5.9M |
| Operating expense | -51.47%4.24M | 6.01%26.97M | 90.84%10.6M | -6.96%5.72M | -10.42%4.72M | 15.77%25.44M | 23.18%5.55M | 56.23%8.73M | 1.05%6.15M | -9.14%5.27M |
| Selling and administrative expenses | -51.47%4.24M | 6.01%26.97M | 90.84%10.6M | -6.96%5.72M | -10.42%4.72M | 15.77%25.44M | 23.18%5.55M | 56.23%8.73M | 1.05%6.15M | -9.14%5.27M |
| -General and administrative expense | -51.47%4.24M | 6.01%26.97M | 90.84%10.6M | -6.96%5.72M | -10.42%4.72M | 15.77%25.44M | 23.18%5.55M | 56.23%8.73M | 1.05%6.15M | -9.14%5.27M |
| Operating profit | -138.70%-908K | -422.73%-10.73M | -214.10%-6.15M | -509.80%-3.89M | -317.30%-1.37M | 158.92%3.33M | 4.81%-1.96M | 302.94%2.35M | 142.18%949K | 446.15%630K |
| Net non-operating interest income (expenses) | 67.61%-80K | 32.71%-648K | 38.29%-245K | 27.65%-123K | 7.61%-170K | -140.75%-963K | -329.48%-397K | -20.49%-247K | 7.61%-170K | 0.00%-184K |
| Non-operating interest income | ---- | ---- | ---- | ---- | ---- | -74.10%258K | ---- | ---- | ---- | ---- |
| Non-operating interest expense | -67.61%80K | -32.71%648K | -38.29%245K | -27.65%123K | -7.61%170K | -30.62%963K | -51.29%397K | 20.49%247K | -7.61%170K | 0.00%184K |
| Total other finance cost | ---- | ---- | ---- | ---- | ---- | 487.50%47K | ---- | ---- | ---- | ---- |
| Net investment income | 68.97%98K | |||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | 63.01%-395K | |||||||||
| Less:Write off | ---- | ---- | ---- | ---- | ---- | -63.01%395K | ---- | ---- | ---- | ---- |
| Other non-operating income (expenses) | 576.21%1.39M | -2,703.13%-45.76M | -2,137.65%-48.92M | 191.30%268K | 4,029.09%2.27M | 2,010.87%1.76M | 142.04%2.4M | 271.67%206K | 122.17%92K | 110.02%55K |
| Income before tax | -82.43%405K | -1,486.68%-57.15M | -120,358.70%-55.32M | -529.85%-3.74M | 46.11%732K | 157.66%4.12M | 102.42%46K | 255.64%2.31M | 130.57%871K | 154.75%501K |
| Income tax | -62.63%105K | -995.81%-15.19M | -1,811.93%-15.49M | 0 | 50.00%150K | 535.21%1.7M | 198.91%905K | -49.82%281K | 105.00%205K | -80.84%100K |
| Net income | -85.18%300K | -1,829.98%-41.95M | -4,536.32%-39.83M | -662.16%-3.74M | 45.14%582K | 132.71%2.43M | 12.97%-859K | 199.17%2.02M | 122.58%666K | 127.91%401K |
| Net income continuous operations | -85.18%300K | -1,829.98%-41.95M | -4,536.32%-39.83M | -662.16%-3.74M | 45.14%582K | 132.71%2.43M | 12.97%-859K | 199.17%2.02M | 122.58%666K | 127.91%401K |
| Noncontrolling interests | 94.74%-6K | -3,772.95%-10.88M | -23,497.83%-10.86M | 93.91%-7K | -300.00%-12K | -401.79%-281K | -161.33%-46K | -115.09%-114K | -187.50%-115K | 92.11%-3K |
| Net income attributable to the company | -85.69%306K | -1,248.15%-31.07M | -3,463.47%-28.97M | -578.49%-3.74M | 47.03%594K | 136.78%2.71M | 23.45%-813K | 207.55%2.14M | 126.85%781K | 128.88%404K |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | -85.69%306K | -1,248.15%-31.07M | -3,463.47%-28.97M | -578.49%-3.74M | 47.03%594K | 136.78%2.71M | 23.45%-813K | 207.55%2.14M | 126.85%781K | 128.88%404K |
| Gross dividend payment | ||||||||||
| Basic earnings per share | -85.19%0.0004 | -1,255.88%-0.0393 | -3,570.00%-0.0367 | -570.00%-0.0047 | 60.00%0.08 | 136.56%0.0034 | 23.08%-0.001 | 208.00%0.0027 | 127.03%0.001 | 2,877.78%0.05 |
| Diluted earnings per share | -85.19%0.0004 | -1,255.88%-0.0393 | -3,570.00%-0.0367 | -570.00%-0.0047 | 60.00%0.08 | 136.56%0.0034 | 25.76%-0.001 | 208.00%0.0027 | 127.03%0.001 | 2,877.78%0.05 |
| Dividend per share | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.